Arena's Belviq 1st Obesity Drug To Get FDA's Nod Since 1999
The U.S. Food and Drug Administration on Wednesday gave its blessing to Arena Pharmaceuticals Inc.'s weight-loss treatment Belviq, the first such approval in more than a decade and a potential milestone...To view the full article, register now.
Already a subscriber? Click here to view full article